Healthy Extracts Inc. (HYEX)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1 | 1 | 2 | 2 | 3 | 5 | 6 | 14 |
| Operating profit | $m | -1 | -1 | ||||||
| Net profit | $m | -3 | -2 | -1 | -2 | -1 | -1 | -1 | 1 |
| EPS reported | $ | -0.09 | -0.16 | ||||||
| Operating cashflow per share | $ | 0.02 | 0.01 | ||||||
| Capex per share | $ | 0.00 | 0.00 | ||||||
| FCF per share | $ | 0.02 | 0.01 | ||||||
| Free cash flow | $m | 0 | 1 | ||||||
| Net debt | $m | 2 | 8 | ||||||
| Book value equity | $m | 24 | 22 | ||||||
| Book value per share | $ | 2.58 | 1.37 | ||||||
| Number of shares | m | 9.31 | 16.34 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.59 | 0.63 | ||||||
| P/S LTM | x | 3.13 | 2.25 | ||||||
| P/FCF LTM | x | 96.73 | 28.27 | ||||||
| EV/EBITDA LTM | x | -21.01 | -34.20 | ||||||
| EV/Sales LTM | x | 3.69 | 0.94 | ||||||
| Earnings Yield LTM | % | -6.23% | -4.93% | ||||||
| FCF Yield | % | +1.03% | +3.54% | ||||||
| Quality | |||||||||
| ROE | % | -3.67% | -3.76% | ||||||
| ROIC | % | -3.49% | -4.37% | ||||||
| Operating margin | % | -20.92% | -22.42% | ||||||
| Gross margin | % | +53.69% | +57.52% | ||||||
| FCF/Sales | % | +3.24% | +3.70% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +44.93% | +102.04% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -48.14% | +77.42% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.06 | 0.06 | ||||||
| Net Debt/EBITDA | x | -3.15 | -4.49 | ||||||
| EBIT/Net interest | x | -4.49 | -4.46 | ||||||
| Net debt/market cap | % | +15.01% | +84.14% | ||||||
| Net debt/Equity | x | 0.08 | 0.38 | ||||||
| Gross debt/equity | x | 0.11 | 0.40 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Healthy Extracts Inc., through its various divisions, specializes in the global and domestic research, development, and sale of natural botanical products. Its portfolio encompasses dietary supplements crafted for cardiovascular wellness, alongside KETONOMICS-branded neuro-enhancers aimed at boosting cognitive functions like memory, mental acuity, concentration, and neural energy. The company further supplies encapsulated bergamot products, available under distinct labels such as BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART. These bergamot offerings are distributed via its online platform and various other channels. Established in 2014 and based in Littleton, Colorado, the company was previously known as Grey Cloak Tech Inc. until its name change in October 2020.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Healthy Extracts Inc., through its various divisions, specializes in the global and domestic research, development, and sale of natural botanical products. Its portfolio encompasses dietary supplements crafted for cardiovascular wellness, alongside KETONOMICS-branded neuro-enhancers aimed at boosting cognitive functions like memory, mental acuity, concentration, and neural energy. The company further supplies encapsulated bergamot products, available under distinct labels such as BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART. These bergamot offerings are distributed via its online platform and various other channels. Established in 2014 and based in Littleton, Colorado, the company was previously known as Grey Cloak Tech Inc. until its name change in October 2020.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free